For citations:
Khlyamov S.V., Mal G.S., Artyushkova E.B., Gladchenko M.P. CHEMOTHERAPY FOR ONCOLOGICAL DISEASES AND THE RISK OF DEVELOPING A CARDIOTOXIC PROFILE ON THE EXAMPLE OF THE HUMAN RECOMBINED MONOCLONAL ANTIBODY BEVACIZUMAB. Innova. 2023;9(1). (In Russ.)
Views PDF (Rus): 126
Email this article 